
ACIP COVID-19 Vaccines Work Group
Frank Ziovas 22 December 2020

Anaphylaxis in UK Following COVID-19 Vaccination
December 8, 2020 –UK initiated vaccination with Pfizer-BioNTechCOVID-19 vaccine
December 9 –UK authorities confirmed 2 cases of anaphylaxis after vaccination
Prescribing information for both Pfizer-BioNTechand ModernaCOVID-19 vaccines contains information on anaphylaxis
Severe allergic reaction (e.g., anaphylaxis) to any component of the vaccine is a contraindication to vaccination
Appropriate medical treatment used to manage immediate allergic reactions must be immediately available in the event an acute anaphylactic reaction occurs following administration of the vaccine
CDC Guidance on Anaphylaxis Following COVID-19 Vaccination
ACIP considered anaphylaxis risk during deliberations on Pfizer-BioNTechCOVID-19 vaccine during December 11-12 meetings
December 12 –CDC published clinical considerations for use of Pfizer-BioNTechCOVID-19 vaccine
Included guidance on contraindications and precautions (https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/clinical-considerations.html#contraindications-precautions)
Download the entire presentation below:
Please share this information